跳至主要内容
临床试验/NCT02272556
NCT02272556已完成不适用

Investigating the Role of Polyol Pathway in the Central Nervous System

Yale University1 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2015年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
138
试验地点
1
主要终点
Metabolite Measurements by MRS

研究概览

简要总结

Patients will undergo magnetic resonance spectroscopy (MRS) scanning to noninvasively measure intracerebral and plasma metabolite levels at baseline and following 2 and 4 hours of hyperglycemia. Subjects will also undergo a lumbar puncture at a separate occasion to assess cerebrospinal fluid levels of metabolites.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Type 2 DM with HbA1C treated with metformin, sulfonylurea, insulin, or combination OR age-matched, non-diabetic obese (BMI > 30 kg/m^2) OR age-matched lean, healthy control subjects (BMI < 25 kg/m^2)
  • •Age 18-55
  • •BMI 18-45 kg/m^2

排除标准

  • •Creatinine > 1.5 mg/dL
  • •Hgb < 10 mg/dL
  • •ALT > 2.5 x ULN
  • •Untreated thyroid disease
  • •Uncontrolled Hypertension
  • •Known Neurological Disorders
  • •Untreated Psychiatric Disorders
  • •Malignancy
  • •Bleeding Disorders
  • •Current or recent steroid use in last 3 months
  • •Illicit drug use
  • •Pregnancy, actively seeking pregnancy, or breastfeeding
  • •Inability to enter MRI/MRS

研究组 & 干预措施

Subjects with Type 2 Diabetes

Active Comparator

Type 2 DM subjects with HbA1C > 7.5% treated with metformin, sulfonylurea, insulin or combination

干预措施: Brain MRS during hyperglycemic clamp (Other)

Subjects with Type 2 Diabetes

Active Comparator

Type 2 DM subjects with HbA1C > 7.5% treated with metformin, sulfonylurea, insulin or combination

干预措施: Analysis of Metabolites in cerebrospinal fluid (Other)

Non-Diabetic Obese

Active Comparator

Age-matched, non-diabetic obese (BMI > 30 kg/m^3) individuals

干预措施: Brain MRS during hyperglycemic clamp (Other)

Non-Diabetic Obese

Active Comparator

Age-matched, non-diabetic obese (BMI > 30 kg/m^3) individuals

干预措施: Analysis of Metabolites in cerebrospinal fluid (Other)

Lean, healthy control subjects

Active Comparator

Age-matched, lean, healthy control subjects (BMI < 25 kkg/m^3)

干预措施: Brain MRS during hyperglycemic clamp (Other)

Lean, healthy control subjects

Active Comparator

Age-matched, lean, healthy control subjects (BMI < 25 kkg/m^3)

干预措施: Analysis of Metabolites in cerebrospinal fluid (Other)

结局指标

主要结局

Metabolite Measurements by MRS

时间窗: 4 hours post hyperglycemia

metabolite levels will be measured by MRS

次要结局

  • Hunger Ratings(4 hours post hyperglycemia)
  • Satiety Ratings(4 hours post hyperglycemia)
  • Cognitive State(4 hours post hyperglycemia)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验